DOI QR코드

DOI QR Code

Chromosomal Abnormalities in Pakistani Children with Acute Lymphoblastic Leukemia

  • Shaikh, Muhammad Shariq (Department of Pathology and Microbiology, The Aga Khan University Hospital) ;
  • Ali, Syed Sarwer (Department of Pathology and Microbiology, The Aga Khan University Hospital) ;
  • Khurshid, Mohammad (Department of Oncology, The Aga Khan University Hospital) ;
  • Fadoo, Zehra (Department of Paediatrics, The Aga Khan University Hospital)
  • 발행 : 2014.05.15

초록

Background: Cytogenetic abnormalities have important implications in diagnosis and prognosis of acute leukemia and are now considered an important part of the diagnostic workup at presentation. Karyotype, if known at the time of diagnosis, guides physicians to plan appropriate management strategies for their patients. Aim and Objectives: To determine the cytogenetic profile of acute lymphoblastic leukemia (ALL) in Pakistani children in order to have insights regarding behavior of the disease. Materials and Methods: A retrospective analysis of all the cases of ALL (<15years old) diagnosed at Aga Khan University from January 2006 to June 2011 was performed. Cytogenetic analysis was made for all cases using the trypsin-Giemsa banding technique. Karyotypes were interpreted using the International System for Human Cytogenetic Nomenclature (ISCN) criteria. Results: A total of 153 patients were diagnosed as ALL during the study period, of which 127 samples successfully yielded metaphase chromosomes. The male to female ratio was 1.8:1. A normal karyotype was present in 51.2% (n=65) of the cases whereas 48.8% (n=62) had an abnormal karyotype. Most of the abnormal cases showed hyperdiploidy(13.4%) followed by t(9;22)(q34;q11.2) (7.08%). Conclusions: This study revealed a relative lack of good prognostic cytogenetic aberrations in Pakistani children with ALL.

키워드

참고문헌

  1. Aburn G, Gott M (2011). Education given to parents of children newly diagnosed with acute lymphoblastic leukemia a narrative review. J Pediatr Oncol Nurs, 28, 300-5. https://doi.org/10.1177/1043454211409585
  2. Arico M, Schrappe M, Hunger SP, et al (2010). Clinical outcome of children with newly diagnosed philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol, 28, 4755-61. https://doi.org/10.1200/JCO.2010.30.1325
  3. Basso G, Veltroni M, Valsecchi MG, et al (2009). Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. J Clin Oncol, 27, 5168-74. https://doi.org/10.1200/JCO.2008.20.8934
  4. Borowitz MJ, Devidas M, Hunger SP, et al (2008). Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a children's oncology group study. Blood, 111, 5477-85. https://doi.org/10.1182/blood-2008-01-132837
  5. Forestier E, Heyman M, Andersen MK, et al (2008). Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival. Br J Haematol, 140, 665-72. https://doi.org/10.1111/j.1365-2141.2008.06980.x
  6. Gil EA, Lajus TB, de Moura TM, et al (2013). Banding cytogenetic analysis in pediatric patients with acute lymphoblastic leukemia (ALL) in a Brazilian population. Mol Cytogenet, 6, 37. https://doi.org/10.1186/1755-8166-6-37
  7. Harrison CJ, Moorman AV, Barber KE, et al (2005). Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. Br J Haematol, 129, 520-30. https://doi.org/10.1111/j.1365-2141.2005.05497.x
  8. Harrison CJ (2009). Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol, 144, 147-56. https://doi.org/10.1111/j.1365-2141.2008.07417.x
  9. Hilden JM, Dinndorf PA, Meerbaum SO, et al (2006). Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the children's oncology group. Blood, 108, 441-51. https://doi.org/10.1182/blood-2005-07-3011
  10. Iacobucci I, Papayannidis C, Lonetti A, et al (2012). Cytogenetic and molecular predictors of outcome in acute lymphoblastic leukemia: recent developments. Curr Hematol Malig Rep, 7, 133-43. https://doi.org/10.1007/s11899-012-0122-5
  11. Landau H, Lamanna N (2006). Clinical manifestations and treatment of newly diagnosed acute lymphoblastic leukemia in adults. Curr Hematol Malig Rep, 1, 171-9. https://doi.org/10.1007/s11899-996-0005-8
  12. Mazloumi SH, Madhumathi DS, Appaji L, Prasannakumari. (2012). Combined study of cytogenetics and fluorescence in situ hybridization (FISH) analysis in childhood acute lymphoblastic leukemia (ALL) in a tertiary cancer centre in South India.. Asian Pac J Cancer Prev, 13, 3825-7. https://doi.org/10.7314/APJCP.2012.13.8.3825
  13. Moorman AV, Chilton L, Wilkinson J, et al (2010). A population-based cytogenetic study of adults with acute lymphoblastic leukemia. Blood, 115, 206-14. https://doi.org/10.1182/blood-2009-07-232124
  14. Moorman AV, Ensor HM, Richards SM, et al (2010). Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol, 11, 429-38. https://doi.org/10.1016/S1470-2045(10)70066-8
  15. Pieters R, Carroll WL (2008). Biology and treatment of acute lymphoblastic leukemia. Pediatr Clin North Am, 55, 1-20. https://doi.org/10.1016/j.pcl.2007.11.002
  16. Pui CH, Robison LL, Look AT (2008). Acute lymphoblastic leukaemia. Lancet, 371, 1030-43. https://doi.org/10.1016/S0140-6736(08)60457-2
  17. Schultz KR, Bowman WP, Aledo A, et al (2009). Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. J Clin Oncol, 27, 5175-81. https://doi.org/10.1200/JCO.2008.21.2514
  18. Soheila K, Hamid A, Farid Z, et al (2013). Comparison of univariate and multivariate gene set analysis in acute lymphoblastic leukemia. Asian Pac J Cancer Prev, 14, 1629-33. https://doi.org/10.7314/APJCP.2013.14.3.1629
  19. Tharnprisan P, Khiewyoo J, Sripraya P, Wiangnon S (2013). Relapse-free rate with childhood acute lymphoblastic leukemia treated under the thai national protocol. Asian Pac J Cancer Prev, 14, 1127-30. https://doi.org/10.7314/APJCP.2013.14.2.1127
  20. Vrooman LM, Silverman LB (2009). Childhood acute lymphoblastic leukemia: update on prognostic factors. Curr Opin Pediatr, 21, 1-8. https://doi.org/10.1097/MOP.0b013e32831f1f24
  21. Yasmeen N, Ashraf S (2009). Childhood acute lymphoblastic leukaemia; epidemiology and clinicopathological features. J Pak Med Assoc, 59, 105-3.

피인용 문헌

  1. Allogeneic Hemopietic Stem Cell Transplants for the Treatment of B Cell Acute Lymphocytic Leukemia vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6127
  2. New Haplotypes of the ATP Synthase Subunit 6 Gene of Mitochondrial DNA are Associated with Acute Lymphoblastic Leukemia in Saudi Arabia vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10433
  3. Cytogenetic Profile of De Novo B lineage Acute Lymphoblastic Leukemia: Determination of Frequency, Distribution Pattern and Identification of Rare and Novel Chromosomal Aberrations in Indian Patients vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7219
  4. Importance of FISH combined with Morphology, Immunophenotype and Cytogenetic Analysis of Childhood/Adult Acute Lymphoblastic Leukemia in Omani Patients vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7343
  5. DNA Ploidy and S-phase Fraction Analysis in Paediatric B-cell Acute Lymphoblastic Leukemia Cases: a Tertiary Care Centre Experience vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7917
  6. Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/middle income population: A multi-institutional report from Pakistan vol.62, pp.10, 2015, https://doi.org/10.1002/pbc.25583